SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 96.0 | -2.2 | 1 | 3 | 83.0 | 0 | 0.0 |
- CAS
- 7558807
- UNII
- KH7I04HPUU
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Auricular (otic) | Solution | 0.13% |
| Auricular (otic) | Suspension | |
| Buccal | Film | 1.09MG |
| Im - Iv | Injection | 1.28% |
| Im - Iv | Powder, For Injection Solution | 1.28% |
| Im - Iv | Solution, Injection | 0.62% |
| Intra-Articular | Injection | |
| Intra-Articular | Suspension | 0.28% |
| Intrabursal | Injection | |
| Intradermal | Injection | |
| Intralesional | Injection | |
| Intralesional | Injection, Sustained Action | |
| Intramuscular | Injection | 0.5% |
| Intramuscular | Injection, Sustained Action | |
| Intramuscular | Powder, For Injection Solution | 0.5% |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 1.2% |
| Intramuscular | Solution, Injection | |
| Intramuscular | Suspension | |
| Intramuscular | Suspension, Injection | 0.5%W/V |
| Intrasynovial | Injection, Sustained Action | |
| Intravascular | Injection | 0.01% |
| Intravenous | Injection | 0.5% |
| Intravenous | Powder, For Injection Solution | 0.71% |
| Intravenous | Solution | 4% |
| Intravesical | Solution | |
| Iv(infusion) | Injection | 0.5% |
| Iv(infusion) | Powder, For Injection Solution | 1.28% |
| Nasal | Spray, Metered | 0.02% |
| Ophthalmic | Drops | 0.35% |
| Ophthalmic | Solution | 0.78% |
| Ophthalmic | Solution, Drops | 0.72% |
| Ophthalmic | Suspension | 0.65% |
| Ophthalmic | Suspension, Drops | 0.06% |
| Oral | Concentrate | |
| Oral | Solution | 4% |
| Oral | Suspension | 0.16% |
| Oral | Syrup | 0.07% |
| Oral | Tablet | 4.18MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 23.4MG |
| Oral | Tablet, Sustained Action, Film Coated | 30.97MG |
| Oral-20 | Tablet | 0.08MG |
| Oral-21 | Tablet | 0.08MG |
| Soft Tissue | Injection, Sustained Action | |
| Subcutaneous | Injection | 3.31% |
| Subcutaneous | Powder, For Injection Solution | 0.08% |
| Subcutaneous | Powder, For Injection Solution, Lyophilized | 0.11% |
| Subcutaneous | Solution, Injection | 0.2% |
| Topical | Emulsion, Cream | 0.3% |
| Topical | Lotion | |
| Topical | Shampoo, Suspension | 1%W/V |
| Topical | Solution | |
| Vaginal | Emulsion, Cream |